XML 33 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets
12 Months Ended
Sep. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

7.    Goodwill and Intangible Assets

Goodwill represents the excess of net book value over the estimated fair value of net tangible and identifiable intangible assets of a reporting unit. Goodwill is tested for impairment annually or more often if impairment indicators are present at the reporting unit level. The Company elected April 1st as its annual goodwill impairment assessment date. If the existence of events or circumstances indicates that it is more likely than not that fair values of the reporting units are below their carrying values, the Company performs additional impairment tests during interim periods to evaluate goodwill for impairment.

In accordance with ASC 350, the Company initially assesses qualitative factors to determine whether the existence of events or circumstances indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company determines, based on this assessment, that it is more likely than not that the fair value of the reporting unit is less than its carrying value, it performs a quantitative goodwill impairment test by comparing the reporting unit’s fair value with its carrying value. An impairment loss is recognized for the amount by which the reporting unit’s carrying value exceeds its fair value, up to the total amount of goodwill allocated to the reporting unit. No impairment loss is recognized if the fair value of the reporting exceeds its carrying value.

 

The Company completed its annual goodwill impairment test as of April 1, 2018 and determined that no adjustment to goodwill was necessary since the fair value of each reporting unit was significantly in excess of the carrying value of each reporting unit. The Company conducted a qualitative assessment for three reporting units within the Brooks Semiconductor Solutions Group segment and determined that it was not likely that their fair values were less than their carrying values. As a result of the analysis, the Company did not perform the quantitative assessment for these reporting units and did not recognize impairment losses. The Company also performed the quantitative goodwill impairment test for the fourth reporting unit within the Brooks Semiconductor Solutions Group segment and for the Brooks Life Sciences reporting unit. The Company determined that no adjustment to goodwill was necessary for these two reporting units since their fair values significantly exceeded their respective carrying values. If events occur or circumstances change that would more likely than not reduce the fair value of any reporting unit below its carrying value, the Company will evaluate such reporting unit’s goodwill for impairment between annual tests.

The following table sets forth the changes in the carrying amount of goodwill by operating segment for the year ended September 30, 2018 and 2017 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Brooks

    

 

 

    

 

 

    

 

 

 

 

Semiconductor

 

 

 

 

 

 

 

 

 

 

Solutions

 

Brooks

 

 

 

 

 

 

 

 

Group

 

Life Sciences

 

Other

 

Total

Gross goodwill, at September 30, 2016

 

$

629,297

 

$

135,301

 

$

26,014

 

$

790,612

Accumulated goodwill impairments

 

 

(588,944)

 

 

 —

 

 

(26,014)

 

 

(614,958)

Goodwill, net of accumulated impairments, at September 30, 2016

 

 

40,353

 

 

135,301

 

 

 —

 

 

175,654

Acquisitions and adjustments

 

 

(19)

 

 

31,519

 

 

 —

 

 

31,500

Gross goodwill, at September 30, 2017

 

$

629,278

 

$

166,820

 

$

26,014

 

$

822,112

Accumulated goodwill impairments

 

 

(588,944)

 

 

 —

 

 

(26,014)

 

 

(614,958)

Goodwill, net of accumulated impairments, at September 30, 2017

 

 

40,334

 

 

166,820

 

 

 —

 

 

207,154

Acquisitions and adjustments

 

 

7,629

 

 

41,093

 

 

 —

 

 

48,722

Gross goodwill, at September 30, 2018

 

 

636,907

 

 

207,913

 

 

26,014

 

 

870,834

Accumulated goodwill impairments

 

 

(588,944)

 

 

 —

 

 

(26,014)

 

 

(614,958)

Goodwill, net of accumulated impairments, at September 30, 2018

 

$

47,963

 

$

207,913

 

$

 —

 

$

255,876

 

 

 

 

 

 

 

 

 

 

 

 

 

During fiscal year 2018, the Company recorded a goodwill increase of $41.0 million primarily related to the acquisitions of 4titude, TecSem and BioSpeciMan.

The components of the Company’s identifiable intangible assets as of September 30, 2018 and 2017 are as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2018

 

September 30, 2017

 

 

 

 

Accumulated

 

Net Book

 

 

 

Accumulated

 

Net Book

 

    

Cost

    

Amortization

    

Value

    

Cost

    

Amortization

    

Value

Patents

 

$

5,302

 

$

4,325

 

$

977

 

$

5,302

 

$

4,019

 

$

1,283

Completed technology

 

 

44,829

 

 

28,934

 

 

15,895

 

 

31,264

 

 

24,379

 

 

6,885

Trademarks and trade names

 

 

6,298

 

 

2,953

 

 

3,345

 

 

6,138

 

 

1,863

 

 

4,275

Customer relationships

 

 

142,489

 

 

62,750

 

 

79,739

 

 

115,596

 

 

44,535

 

 

71,061

 

 

$

198,918

 

$

98,962

 

$

99,956

 

$

158,300

 

$

74,796

 

$

83,504

 

Amortization expense for intangible assets was $24.2 million, $17.1 million and $14.8 million, respectively, for the fiscal years ended September 30, 2018, 2017 and 2016.

Estimated future amortization expense for the intangible assets as of September 30, 2018 is as follows (in thousands):

 

 

 

 

Fiscal year ended September 30, 

    

 

  

2019

 

$

23,187

2020

 

 

21,061

2021

 

 

14,752

2022

 

 

11,839

2023

 

 

9,423

Thereafter

 

 

19,694

 

 

$

99,956